EDN1 and hyperinsulinism: Both Ferri et al. [27] and Piatti et al. [28] proved that there is a correlation between plasma levels of ET-1 and dosage (and timing) of insulin administered to euglycemic patients with type 2 DM and hyperinsulinemia.